0001179110-15-008413.txt : 20150522
0001179110-15-008413.hdr.sgml : 20150522
20150522073202
ACCESSION NUMBER: 0001179110-15-008413
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150520
FILED AS OF DATE: 20150522
DATE AS OF CHANGE: 20150522
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001600132
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473116175
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 53 FRONTAGE ROAD, SUITE 301
CITY: HAMPTON
STATE: NJ
ZIP: 08827
BUSINESS PHONE: 908-574-4770
MAIL ADDRESS:
STREET 1: 53 FRONTAGE ROAD, SUITE 301
CITY: HAMPTON
STATE: NJ
ZIP: 08827
FORMER COMPANY:
FORMER CONFORMED NAME: Bellerophon Therapeutics LLC
DATE OF NAME CHANGE: 20140213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Peacock Jonathan M
CENTRAL INDEX KEY: 0001500241
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36845
FILM NUMBER: 15884510
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320-1799
4
1
edgar.xml
FORM 4 -
X0306
4
2015-05-20
0
0001600132
Bellerophon Therapeutics, Inc.
BLPH
0001500241
Peacock Jonathan M
C/O BELLEROPHON THERAPEUTICS, INC.
53 FRONTAGE ROAD, SUITE 301
HAMPTON
NJ
08827
1
1
0
0
President and CEO
Common Stock
2015-05-20
4
P
0
5560
8.6912
A
26427
D
The price reported represents the weighted average sales price of shares purchased in multiple transactions at prices ranging from $8.39 to $8.93 per share. The reporting person hereby undertakes, upon the request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
/s/ Manesh Naidu, as Attorney-in-Fact for Jonathan M. Peacock
2015-05-22